D002066Chemicals & DrugsD02.033.455.125.125D02.455.326.146.100.050.500.100D02.886.645.600.055.050.510.10020390.979699Busulfanprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson1.217710.015954420research area of0.7669730.0045752436subject area forObstetrics and Gynecology29844205Harris AC, Boelens JJ, Ahn KW, Fei M, Abraham A, Artz A, Dvorak C, Frangoul H, Freytes C, Gale RP, Hong S, Lazarus HM, Loren A, Mineishi S, Nishihori T, O'Brien T, Williams K, Pasquini MC, Levine JEBlood advancesComparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine. Blood Adv. 2018 06 12; 2(11):1198-1206.Blood Adv2018-06-12T00:00:002018Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine.29928989Strouse C, Zhang Y, Zhang MJ, DiGilio A, Pasquini M, Horowitz MM, Lee S, Ho V, Ramanathan M, Chinratanalab W, Loren A, Burns LJ, Artz A, Villa KF, Saber WBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow TransplantationRisk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant. Biol Blood Marrow Transplant. 2018 10; 24(10):2072-2080.Biol Blood Marrow Transplant2018-06-19T00:00:002018Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant.29197676Kebriaei P, Anasetti C, Zhang MJ, Wang HL, Aldoss I, de Lima M, Khoury HJ, Sandmaier BM, Horowitz MM, Artz A, Bejanyan N, Ciurea S, Lazarus HM, Gale RP, Litzow M, Bredeson C, Seftel MD, Pulsipher MA, Boelens JJ, Alvarnas J, Champlin R, Forman S, Pullarkat V, Weisdorf D, Marks DI, Acute Leukemia Committee of the CIBMTRBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow TransplantationIntravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia. Biol Blood Marrow Transplant. 2018 04; 24(4):726-733.Biol Blood Marrow Transplant2017-12-25T00:00:002017Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.32476524Hsu J, Van Besien K, Baron FLeukemia & lymphomaBusulfan or melphalan: is there a better conditioning regimen for allogeneneic transplantation? Leuk Lymphoma. 2020 07; 61(7):1529-1534.Leuk Lymphoma2020-05-30T00:00:002020Busulfan or melphalan: is there a better conditioning regimen for allogeneneic transplantation?AymanAl-HendyAyman Al-Hendy41.7886000000000087.598699999999993954Al-Hendy, AymanProfessorKoenVan BesienKoen Van Besien0.000000000000000.000000000000002944Van Besien, KoenPROFESSORMedicine-Hematology and Oncology31376591Schofield RC, Landau HJ, Giralt SA, Shah GL, Scordo M, Lin A, Zanutto E, Ramanathan LV, Pessin MS, Carlow DCJournal of chromatography. B, Analytical technologies in the biomedical and life sciencesMeasurement of the DNA alkylating agents busulfan and melphalan in human plasma by mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Sep 01; 1125:121711.J Chromatogr B Analyt Technol Biomed Life Sci2019-07-04T00:00:002019Measurement of the DNA alkylating agents busulfan and melphalan in human plasma by mass spectrometry.MedicinePathologyUniversity of ChicagoRichard A.LarsonRichard A. Larson41.78927490000000-87.601250000000001169Larson, Richard A.ProfessorJohnHartJohn Hart41.78927490000000-87.60125000000000470Hart, JohnProfessorPeter H.O'DonnellPeter H. O'Donnell41.78927490000000-87.60125000000000537O'Donnell, Peter H.Associate Professortrue1PROFESSORPROFESSORtrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor